Boston Scientific Sells 2 Businesses
303420
The Boston Scientific Corporation, the maker of medical devices, said on Thursday that it had agreed to sell its fluid management and venous access businesses for $425 million to the private equity firm Avista Capital Partners.
434688
A Boston landmark changed hands yesterday, as the Rouse Company , the developer and owner of Faneuil Hall Marketplace, agreed to be purchased by General Growth Properties Inc. of Chicago.
586414
Boston Scientific Corp. said Wednesday it expects overall third-quarter sales will miss analyst expectations as preliminary August sales of its Taxus heart device, which was involved in
415865
With sales of its top medical devices continuing to drop, Boston Scientific Corp. plans broad job cuts that could affect its Massachusetts employees, a spokesman said yesterday.
494872
Boston Scientific Corp. , the state's largest life-science company, lost $3.6 billion last year thanks to its expensive acquisition of heart-device maker Guidant Corp. , and executives said yesterday they weren't certain when sales of its most important products would begin to recover from their slump.
536287
Boston Scientific Corp. BSX.N on   Thursday issued preliminary sales and earnings results for the   third quarter below Wall Street expectations and its shares   fell nearly 4 percent in after-hours trading.
311263
Boston Scientific Corp. BSX.N, whose  Taxus heart device has been involved in a major recall, said on  Wednesday preliminary August sales of the device slowed to $200  million from $207 million reported in July, and issued an  outlook that was below Wall Street estimates.
474513
By The Bellingham Herald, Wash.  Mar. 6--A major Bellingham shopping center was recently sold by one limited liability firm to another.
512814
Boston Scientific Corp. said yesterday it sold $8.3 million worth of its Taxus drug-coated cardiac stents per day this month, a record level the Natick medical-devices giant said demonstrates it has won back doctors' confidence after three recalls.
105301
Boston Scientific Corp. (BSX.N: Quote, Profile, Research) said on Wednesday it already recovered market share for its popular heart device after a recent recall
100249
Beacon Capital Partners LLC has agreed to buy Bay Colony Corporate Center, a prominent office complex on Route 128 in Waltham, for $274 million, according to real estate executives involved in the deal.
606574
Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for &#36;590 million in cash and stock to the private U.S. investment groups Cerberus Capital Management and Ampersand Ventures.
557205
Boston Scientific Corp. said last night that sales of its two key products, stents and implantable defibrillators, were slowing down and were likely to drag its third-quarter profit well below Wall Street expectations.
374364
Boston Scientific Corp. wants to get deeper under your skin. Lawrence C. Best, its chief financial officer, says the company will make more than $2 billion worth of deals over the next two years, many of them in technologies that play a much more invasive medical role, compared to Boston Scientific's traditional products.
202257
Bank of America Corp. moved a second major division away from Boston yesterday despite its repeated pledges to keep key business units headquartered here after it acquired New England's largest bank.
518261
Medical device maker Boston Scientific Corp. said Tuesday that it made an equity investment in Reva Medical Inc. and secured an exclusive option to purchase the privately held San Diego firm, which is developing
444459
The real estate arm of Sun Health has sold off 10 medical office buildings totaling more than $46 million. This move follows a national trend for hospital systems to divest themselves of